BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 28193509)

  • 1. Pilot study analyzing automated ECG screening of hypertrophic cardiomyopathy.
    Campbell MJ; Zhou X; Han C; Abrishami H; Webster G; Miyake CY; Sower CT; Anderson JB; Knilans TK; Czosek RJ
    Heart Rhythm; 2017 Jun; 14(6):848-852. PubMed ID: 28193509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrocardiography Screening for Hypertrophic Cardiomyopathy.
    Campbell MJ; Zhou X; Han C; Abrishami H; Webster G; Miyake CY; Knilans TK; Czosek RJ
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):944-50. PubMed ID: 27346569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computerized Q wave dimensions in athletes and hypertrophic cardiomyopathy patients.
    Bent RE; Wheeler MT; Hadley D; Froelicher V; Ashley E; Perez MV
    J Electrocardiol; 2015; 48(3):362-7. PubMed ID: 25732098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of false negative electrocardiograms in preparticipation screening of athletes for hypertrophic cardiomyopathy.
    Rowin EJ; Maron BJ; Appelbaum E; Link MS; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron MS
    Am J Cardiol; 2012 Oct; 110(7):1027-32. PubMed ID: 22809754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical meaning of isolated increase of QRS voltages in hypertrophic cardiomyopathy versus athlete's heart.
    Calore C; Zorzi A; Corrado D
    J Electrocardiol; 2015; 48(3):373-9. PubMed ID: 25595718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYBPC3 hypertrophic cardiomyopathy can be detected by using advanced ECG in children and young adults.
    Fernlund E; Liuba P; Carlson J; Platonov PG; Schlegel TT
    J Electrocardiol; 2016; 49(3):392-400. PubMed ID: 27061026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrocardiographic abnormalities in elite high school athletes: comparison to adolescent hypertrophic cardiomyopathy.
    Thompson AJ; Cannon BC; Wackel PL; Horner JM; Ackerman MJ; O'Leary PW; Eidem BW; Johnson JN
    Br J Sports Med; 2016 Jan; 50(2):105-10. PubMed ID: 26729893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.
    Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F
    Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hypertrophic cardiomyopathy on an electrocardiogram-based pre-participation screening programme in a young male South-East Asian population: results from the Singapore Armed Forces Electrocardiogram and Echocardiogram screening protocol.
    Ng CT; Chee TS; Ling LF; Lee YP; Ching CK; Chua TS; Cheok C; Ong HY
    Europace; 2011 Jun; 13(6):883-8. PubMed ID: 21486912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spatial QRS-T angle outperforms the Italian and Seattle ECG-based criteria for detection of hypertrophic cardiomyopathy in pediatric patients.
    Cortez D; Sharma N; Cavanaugh J; Tuozo F; Derk G; Lundberg E; Schlegel TT; Weiner K; Kiciman N; Alejos J; Landeck B; Aboulhosn J; Miyamoto S; Batra A; McCanta AC
    J Electrocardiol; 2015; 48(5):826-33. PubMed ID: 26275983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrocardiographic screening for hypertrophic cardiomyopathy and long QT syndrome: the drivers of cost-effectiveness for the prevention of sudden cardiac death.
    Anderson BR; McElligott S; Polsky D; Vetter VL
    Pediatr Cardiol; 2014 Feb; 35(2):323-31. PubMed ID: 24005901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ECG-derived spatial QRS-T angle is strongly associated with hypertrophic cardiomyopathy.
    Cortez D; Schlegel TT; Ackerman MJ; Bos JM
    J Electrocardiol; 2017; 50(2):195-202. PubMed ID: 27839835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.
    Maron BJ
    Cardiol Clin; 2007 Aug; 25(3):399-414, vi. PubMed ID: 17961794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hypertrophic cardiomyopathy is improved when using advanced rather than strictly conventional 12-lead electrocardiogram.
    Potter SL; Holmqvist F; Platonov PG; Steding K; Arheden H; Pahlm O; Starc V; McKenna WJ; Schlegel TT
    J Electrocardiol; 2010; 43(6):713-8. PubMed ID: 21040828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the American Heart Association ( AHA ) 14-Point Evaluation Versus Electrocardiography for the Cardiovascular Screening of High School Athletes: A Prospective Study.
    Williams EA; Pelto HF; Toresdahl BG; Prutkin JM; Owens DS; Salerno JC; Harmon KG; Drezner JA
    J Am Heart Assoc; 2019 Jul; 8(14):e012235. PubMed ID: 31286819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three ECG criteria for athlete pre-participation screening.
    Pickham D; Zarafshar S; Sani D; Kumar N; Froelicher V
    J Electrocardiol; 2014; 47(6):769-74. PubMed ID: 25155389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost Implications of Using Different ECG Criteria for Screening Young Athletes in the United Kingdom.
    Dhutia H; Malhotra A; Gabus V; Merghani A; Finocchiaro G; Millar L; Narain R; Papadakis M; Naci H; Tome M; Sharma S
    J Am Coll Cardiol; 2016 Aug; 68(7):702-11. PubMed ID: 27515329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for efficacy of the Italian national pre-participation screening programme for identification of hypertrophic cardiomyopathy in competitive athletes.
    Pelliccia A; Di Paolo FM; Corrado D; Buccolieri C; Quattrini FM; Pisicchio C; Spataro A; Biffi A; Granata M; Maron BJ
    Eur Heart J; 2006 Sep; 27(18):2196-200. PubMed ID: 16831826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
    Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
    J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
    McLeod CJ; Ackerman MJ; Nishimura RA; Tajik AJ; Gersh BJ; Ommen SR
    J Am Coll Cardiol; 2009 Jul; 54(3):229-33. PubMed ID: 19589435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.